KSC · 009290.KS
Kwang Dong Pharmaceutical Co., Ltd.
₩6,240-₩70 (-1.11%)
Kwang Dong Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.25% below the high.
Loading market information…
KSC · 102460.KS · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
REYON Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
REYON Pharmaceutical Co., Ltd.’s forward annual dividend is ₩177 per share, paid annual. The forward yield is 1.89% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow REYON Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating both domestically in South Korea and across international markets, REYON Pharmaceutical Co., Ltd. specializes in the production and distribution of pharmaceutical products and active pharmaceutical ingredients (APIs). The company's diverse range of offerings addresses various therapeutic areas, including adrenal corticosteroids; angiotensin II receptor antagonists; anticholinergics; antiemetics; antihypertensives; anti-inflammatory enzymes; lipid-lowering, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer treatments; antispasmodics; benign prostatic hypertrophy therapies; cough and cold remedies; cardiac stimulants; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis medications; local anesthetics; migraine drugs; a variety of cardiovascular system drugs; medications for neuromuscular disorders; nootropics and neurotonics; non-steroidal anti-inflammatory drugs (NSAIDs); respiratory stimulants; skeletal muscle relaxants; and vasodilators. Established in 1955, REYON Pharmaceutical Co., Ltd. maintains its corporate headquarters in Seoul, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:37 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩6,240-₩70 (-1.11%)
Kwang Dong Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.25% below the high.
₩3,965-₩35 (-0.88%)
JW Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 16.0% below the high.
₩19,250-₩120 (-0.62%)
Samjin Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.68% below the high.
₩35,600+₩200 (+0.56%)
Chong Kun Dang Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 35.97% below the high.
₩7,650-₩40 (-0.52%)
Samil Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 40.51% below the high.
₩10,510-₩80 (-0.76%)
JW Lifescience Corporation’s quoted price sits in the lower half of its reported 52-week range, 32.54% below the high.
₩8,070-₩160 (-1.94%)
Hana Pharm Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.3% below the high.
₩5,090-₩220 (-4.14%)
AptaBio Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 53.26% below the high.
